Athira KV, Bandopadhyay S, Samudrala PK, Naidu V, Lahkar M, Chakravarty S. An overview of the heterogeneity of major depressive disorder: current knowledge and future prospective. Curr Neuropharmacol. 2020;18(3):168–87.
Article CAS PubMed PubMed Central Google Scholar
Bonanni L, Gualtieri F, Lester D, Falcone G, Nardella A, Fiorillo A, et al. Can anhedonia be considered a suicide risk factor? A review of the literature. Medicina. 2019;55(8):458.
Article PubMed PubMed Central Google Scholar
Guineau MG, Ikani N, Rinck M, Collard R, Van Eijndhoven P, Tendolkar I, et al. Anhedonia as a transdiagnostic symptom across psychological disorders: a network approach. Psychol Med. 2023;53(9):3908–19.
Šagud M, Šimunović Filipčić I, Jakšić NJ, Šimunić LŠ, Jezernik D, Tudor L, et al. Anhedonia in schizophrenia: Mini-review. Psychiatr Danub. 2019;31(suppl 2):143–7.
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. Am Psychiatric Assoc. 2010; p. 748–51.
Serretti A. Anhedonia and depressive disorders. Clin Psychopharmacol Neurosci. 2023;21(3):401–9.
Article CAS PubMed PubMed Central Google Scholar
Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537–55.
Barbano MF, Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology. 2007;191(3):497–506.
Article CAS PubMed Google Scholar
Cao B, Park C, Subramaniapillai M, Lee Y, Iacobucci M, Mansur RB, et al. The efficacy of vortioxetine on anhedonia in patients with major depressive disorder. Front Psych. 2019;10: 434932.
Mazza M, Squillacioti MR, Pecora RD, Janiri L, Bria P. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. Psychiatry Res. 2009;165(1):193–6.
Article CAS PubMed Google Scholar
Whitton AE, Pizzagalli DA. Anhedonia in depression and bipolar disorder. Curr Top Behav Neurosci. 2022; 58: p. 111–27.
Liang S, Wu Y, Hanxiaoran L, Greenshaw AJ, Li T. Anhedonia in depression and schizophrenia: brain reward and aversion circuits. Neuropsychiatr Dis Treat. 2022;18:1385.
Article PubMed PubMed Central Google Scholar
Craske MG, Meuret AE, Ritz T, Treanor M, Dour H, Rosenfield D. Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia. J Consult Clin Psychol. 2019;87(5):457.
Taylor CT, Hoffman SN, Khan AJ. Anhedonia in anxiety disorders. Anhedonia Preclin Transl Clin Integr. 2022;58:201–18.
Turner V, Husain M. Anhedonia in neurodegenerative diseases. Anhedonia Preclin Transl Clin Integr. 2022; p. 255-77.
Saz P, López-Antón R, Dewey M, Ventura T, Martin A, Marcos G, et al. Prevalence and implications of psychopathological non-cognitive symptoms in dementia. Acta Psychiatr Scand. 2009;119(2):107–16.
Article CAS PubMed Google Scholar
Stull SW, Bertz JW, Epstein DH, Bray BC, Lanza ST. Anhedonia and substance use disorders by type, severity, and with mental health disorders. J Addict Med. 2022;16(3): e150.
Article CAS PubMed PubMed Central Google Scholar
Ceres R, Cascino G. Anhedonia in anorexia nervosa: a narrative review. J Psychopathol. 2024;30:44-52
Dolan SC, Khindri R, Franko DL, Thomas JJ, Reilly EE, Eddy KT. Anhedonia in eating disorders: a meta-analysis and systematic review. Int J Eat Disord. 2022;55(2):161–75.
Downar J, Geraci J, Salomons TV, Dunlop K, Wheeler S, McAndrews MP, et al. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biol Psychiat. 2014;76(3):176–85.
Winer ES, Jordan DG, Collins AC. Conceptualizing anhedonias and implications for depression treatments. Psychol Res Behav Manag. 2019;12:325–35.
Khazanov GK, Forbes CN, Dunn BD, Thase ME. Addressing anhedonia to increase depression treatment engagement. Br J Clin Psychol. 2022;61(2):255–80.
Spijker J, Bijl R, De Graaf R, Nolen W. Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand. 2001;103(2):122–30.
Article CAS PubMed Google Scholar
McIntyre RS, Woldeyohannes HO, Soczynska JK, Maruschak NA, Wium-Andersen IK, Vinberg M, et al. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project. CNS Spectr. 2016;21(5):362–6.
Auerbach RP, Pagliaccio D, Kirshenbaum JS. Anhedonia and suicide. Curr Top Behav Neurosci. 2022;58:443–64.
Gillissie ES, Le GH, Rhee TG, Cao B, Rosenblat JD, Mansur RB, et al. Evaluating Anhedonia as a risk factor in suicidality: a meta-analysis. J Psychiatric Res. 2023. 158: p. 209-215
Ducasse D, Dubois J, Jaussent I, Azorin JM, Etain B, Gard S, et al. Association between anhedonia and suicidal events in patients with mood disorders: a 3-year prospective study. Depress Anxiety. 2021;38(1):17–27.
Ducasse D, Loas G, Dassa D, Gramaglia C, Zeppegno P, Guillaume S, et al. Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis. Depress Anxiety. 2018;35(5):382–92.
Poletti M, Pelizza L, Loas G, Azzali S, Paterlini F, Garlassi S, et al. Anhedonia and suicidal ideation in young people with early psychosis: further findings from the 2-year follow-up of the ReARMS program. Psychiatry Res. 2023;323: 115177.
Bonanni L, Gualtieri F, Lester D, Falcone G, Nardella A, Fiorillo A, et al. Can anhedonia be considered a suicide risk factor? A review of the literature. Medicina (Kaunas). 2019;55(8).
Jahn DR, Bennett ME, Park SG, Gur RE, Horan WP, Kring AM, et al. The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia. Schizophr Res. 2016;170(2–3):271–7.
Loas G, Azi A, Noisette C, Legrand A, Yon V. Fourteen-year prospective follow-up study of positive and negative symptoms in chronic schizophrenic patients dying from suicide compared to other causes of death. Psychopathology. 2009;42(3):185–9.
Sher L, Kahn RS. Suicide in schizophrenia: AN educational overview. Medicina (Kaunas). 2019;55(7).
Bress JN, Arslanoglou E, Banerjee S, Alexopoulos GS, Kiosses DN. Positive valence system function and anhedonia in middle-aged and older adults at high suicide risk. Biol Psychol. 2023;182: 108647.
Burton TJ, Balleine BW. The positive valence system, adaptive behaviour and the origins of reward. Emerg Top Life Sci. 2022;6(5):501–13.
Article PubMed PubMed Central Google Scholar
Hasratian AM, Meuret AE, Chmielewski M, Ritz T. An examination of the RDoC negative valence systems domain constructs and the self-reports unit of analysis. Behav Ther. 2022;53(6):1092–108.
Craske MG, Meuret AE, Ritz T, Treanor M, Dour HJ. Treatment for anhedonia: a neuroscience driven approach. Depress Anxiety. 2016;33(10):927–38.
Gard DE, Gard MG, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: A scale development study. Journal of Research in Personality. 2006;40(6):1086-1102.
Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167(1):99–103.
Article CAS PubMed Google Scholar
Ameli R, Luckenbaugh DA, Gould NF, Holmes MK, Lally N, Ballard ED, et al. SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration. PeerJ. 2014;2: e429.
Article PubMed PubMed Central Google Scholar
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.
Article CAS PubMed Google Scholar
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Comments (0)